Comprehensive analysis of the NSCLC tumor ecosystem identified B7 homolog 3 protein (B7H3, also known as CD276) as a type I transmembrane protein that is broadly overexpressed by malignant cells and tumor-associated cells, but with restricted expression in normal tissues [12, 13]. Here, CD276 is linked to neoplasm.